Investment activity in telemedicine booths has picked up over the past month with Babylon leading a Series B of US-based Higi and France-based H4D closing a €15m round. H4D's founder tells HBI that it's a half a billion potential market in France alone.
German hospital operator Rhoen Klinikum, currently the target of a takeover bid by competitor Asklepios, looks set to part ways with its current CEO Stephen Holzinger.
Ping An's early-stage investment arm Voyager Fund has invested in Berlin-based dental healthtech group PlusDental. We examine PlusDental's business model and talk to CEO Peter Baumgart who says demand has surged back in DACH.
Will Covid-19 be a game changer for the lab sector? The prospect of big government contracts and a massive, unserved B2C market is drawing new players into the diagnostic lab sector. Could they have a permanent impact?
China's largest digital health platform Ping An Good Doctor is reportedly losing its CEO, COO, Chief Technology Officer, Chief Product Officer and Company Secretary. Is it trying to shift the platform into a more profitable B2B strategy?
Spain and Israel's General Practitioners (GPs) rank among the worst paid in the OECD when accounting for purchasing power. HBI looks at a new healthcare salary index to compare pay across the world.
Making sense of the money markets isn't easy right now. But some big players - Ramsay, Zur Rose and TPG are still raising money and some sectors such as German outpatient are still seeing M&A consolidation.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
